2023. Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s162. DOI:https://doi.org/10.25251/skin.7.supp.162.